New CAR t therapy takes on Hard-to-Treat solid tumors
NCT ID NCT06193902
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This early-stage trial tests a new treatment called LEU011 for people with solid tumors that have not responded to standard therapies or have returned. LEU011 uses a patient's own immune cells, modified to better recognize and attack cancer cells. The main goals are to check safety, find the best dose, and see if it helps shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR, SOLID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guy's and St Thomas' NHS Foundation Trust
RECRUITINGLondon, SE1 9RT, United Kingdom
Contact
Contact Phone: •••-•••-••••
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
Contact
Contact
Conditions
Explore the condition pages connected to this study.